To investigate the functional role of S100A8/A9 in AML, we transduced AML cells with shRNAs targeting S100A8 or S100A9. Knockdown efficiency was confirmed by qRT-PCR and Western blot (Fig. S6A–D). This evidence concerns the gene S100A9 and acute myeloid leukemia.